Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease

Background and purpose: Cerebral microbleeds (CMBs) could contribute to an increased risk of intracerebral hemorrhage in patients with antithrombotic therapy (antiplatelets or anticoagulants). Antithrombotic agents are commonly prescribed to the patients with atrial fibrillation (AF) and/or rheumati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Neurol
Autors principals: Cheng, Yajun, Liu, Junfeng, Zhang, Shuting, Li, Jie, Wei, Chenchen, Wang, Deren, Lin, Jing, Wang, Yanan, Wu, Bo, Zhang, Shihong, Liu, Ming
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Neurology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336764/
https://ncbi.nlm.nih.gov/pubmed/30687227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.01184
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars